Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Stemtech Secures Inventory Funding
Healthcare & PharmaceuticalCompany Update

Stemtech Secures Inventory Funding

April 7, 2026 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, secures funding for production of $2.5 Million of Inventory to protect against supply chain interruptions. (Stemtech Corporation - OTCID:STEK) "Live Longer - Live Better - Live Younger" Stemtech announces that we have successfully secured funding to acquire raw materials and components for production of $2.5 million of inventory. This strategic investment, already in...

Read more
Medical Care Technologies Builds on Strong Annual Results as Snapshot Recipes iHeart Podcast Campaign Goes Live Today
Healthcare & PharmaceuticalPartnerships

Medical Care Technologies Builds on Strong Annual Results as Snapshot Recipes iHeart Podcast Campaign Goes Live Today

April 7, 2026 8:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today provided an update as its previously announced podcast marketing campaign for Snapshot Recipes officially goes live today, marking a continued step forward following the Company's recently reported strong annual results. After delivering solid annual performance across its business segments, the Company is now executing on its growth strategy with the rollout of a coordinated...

Read more
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs

April 7, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced the closing of a second convertible preferred stock financing of $2 million under prior commitment in November 2025 of up to $20 million funding available over 24 months. The capital will maintain Ensysce's flagship analgesic programs, while supporting general corporate...

Read more
Pharma Fusion Acquisition of Columbia Pharmacy
Healthcare & PharmaceuticalMergers and Acquisitions

Pharma Fusion Acquisition of Columbia Pharmacy

April 7, 2026 8:00 AM

Pharma Fusion, a leading national specialty pharmacy organization, today announced the acquisition of Columbia Pharmacy, a respected Chicago-based specialty and 340B pharmacy provider. This transaction marks a defining milestone in Pharma Fusion's growth trajectory, significantly expanding its clinical footprint and elevating specialized services for patients living with complex, rare, and chronic conditions across the United States. By...

Read more
AlzeCure Pharma to Present at Redeye Healthcare Day on April 14
Healthcare & PharmaceuticalCompany Update

AlzeCure Pharma to Present at Redeye Healthcare Day on April 14

April 7, 2026 4:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that it will participate at Redeye Healthcare Day on April 14, where CEO Martin Jönsson will give a company presentation and answer questions about the latest developments and AlzeCure's plans for the future. The participation will be broadcast live...

Read more
Dosell AB Awarded Contract with Region Jönköping County and its Municipalities
Healthcare & PharmaceuticalCompany Update

Dosell AB Awarded Contract with Region Jönköping County and its Municipalities

April 7, 2026 3:15 AM

iZafe Group AB (publ)(STO:IZAFE-B) today announces that its subsidiary Dosell AB has been awarded a sub-contract within Region Jönköping County's procurement of medication dispensing systems. The procurement covers a coordinated acquisition between Region Jönköping County and all municipalities within the county, establishing a joint structure for the implementation of digital medication management across the region. Dosell has been awarded...

Read more
BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
Healthcare & PharmaceuticalCompany Update

BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries

April 7, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the official registration of unitary effect for European Patent No. 4539857 covering the Company's proprietary sublingual cladribine oral thin film (ODF) platform. The European Patent Office registered the patent's unitary effect on March 31, 2026, with effect from March...

Read more
Naori Synbiotics Review 2026: Is This Gut Health Supplement Worth Buying?
Healthcare & PharmaceuticalAdvertorial

Naori Synbiotics Review 2026: Is This Gut Health Supplement Worth Buying?

April 6, 2026 10:45 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you have existing health conditions, are taking medications, or are pregnant or nursing. This is not a replacement for prescribed medical treatment. This article contains affiliate links. If you click on these links and make a purchase, a...

Read more
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
Healthcare & PharmaceuticalConferences

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

April 6, 2026 6:01 PM

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, its investigational seasonal influenza vaccine, and for mRESVIA® (mRNA-1345), its mRNA respiratory syncytial virus (RSV) vaccine, at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, Germany, on April 17-21, 2026. Moderna's presentation,...

Read more
NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study
Healthcare & PharmaceuticalCompany Update

NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study

April 6, 2026 5:00 PM

NX Development Corp (NXDC) is pleased to announce that after successfully completing the data analysis of our MEN-301 Study of the use of Gleolan® (aminolevulinic acid HCl) to enhance visualization of newly diagnosed or recurrent meningioma, we have submitted these data to the FDA for review as part of an efficacy supplement to our Gleolan New Drug Application (NDA). "This marks the first submission of supplemental data to the FDA since our...

Read more
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
Healthcare & PharmaceuticalEarnings

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

April 6, 2026 4:00 PM

Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026. The Quarterly Update reflects SBC's Q4:25 financial results, ongoing business transition, and outlook for a return to revenue growth in...

Read more
Revolutionary Cancer Company Oncosure Testing Announces New Non-Executive Advisory Board
Healthcare & PharmaceuticalCompany Update

Revolutionary Cancer Company Oncosure Testing Announces New Non-Executive Advisory Board

April 6, 2026 12:00 PM

Advanced Oncosure Testing Inc., ("OncoSure Testing") an early detection cancer screening company focused on non-evasive, and cost efficient cancer detection announced today that it has created a new Non-Executive Advisory Board to help strategically guide the company through growth and testing protocols. In one simple blood draw, OncoSure Testing tests for Oncosomes which are microscopic, cancer-associated extracellular vesicles. By isolating...

Read more
MyPlanAdvocate Rebrands as MPA and Integrates HealthyLabs, Bringing AI-Powered Performance Marketing In-House
Healthcare & PharmaceuticalCompany Name Change

MyPlanAdvocate Rebrands as MPA and Integrates HealthyLabs, Bringing AI-Powered Performance Marketing In-House

April 6, 2026 10:00 AM

MyPlanAdvocate today announced its new brand identity as MPA. At the same time, the company announced the integration of HealthyLabs into MPA, bringing performance marketing and lead generation capabilities fully in-house. The combined company now unites brokerage, technology, and performance marketing under one brand at mpa.com. With the integration of HealthyLabs, MPA adds AI-driven lead scoring, multi-channel campaign management, and...

Read more
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Healthcare & PharmaceuticalCompany Update

Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board

April 6, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced formation of an Acute Kidney Injury (AKI) Advisory Board for the upcoming Phase 2/3 AKI clinical trial. This distinguished panel brings together internationally recognized Nephrologists and Critical Care Physicians who will guide the company's...

Read more
IAVI Begins First-in-Human Phase 1 Trial of Single-Dose Marburg Virus Vaccine Candidate
Healthcare & PharmaceuticalProduct Announcements

IAVI Begins First-in-Human Phase 1 Trial of Single-Dose Marburg Virus Vaccine Candidate

April 6, 2026 9:00 AM

No vaccines are approved specifically for the prevention of Marburg virus disease Marburg virus disease outbreaks seem to be increasing in frequency. Three outbreaks have occurred in sub-Saharan Africa in the past 18 months. The disease has an average case-fatality rate of about 65%.[1] Marburg virus is determined by the Department of Homeland Security to present a material threat to U.S. national security and is a Public Health Emergency...

Read more
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
Healthcare & PharmaceuticalEarnings

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

April 6, 2026 8:30 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the filing of its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025. 2025 Highlights Revenue of $36.3 million, representing a 4.1% increase compared to 2024. $2.46 million in gross proceeds raised...

Read more
Infinity Chem Announces Exosomes Research Focus
Healthcare & PharmaceuticalCompany Update

Infinity Chem Announces Exosomes Research Focus

April 6, 2026 8:20 AM

Infinity Chem, operating through 8chem.com, today announced an expanded research focus around exosomes and extracellular vesicle science with the release of its new feature, "Exosomes - The Future of Regenerative Science." The announcement reflects the company's broader commitment to research-use-only materials, technical transparency, and scientifically grounded content for laboratories working in regenerative science, extracellular vesicle...

Read more
MDCE's Snapshot Recipes App Scales Marketing Strategy Beyond Initial Podcast Deals with Expanded iHeart Campaign
Healthcare & PharmaceuticalPartnerships

MDCE's Snapshot Recipes App Scales Marketing Strategy Beyond Initial Podcast Deals with Expanded iHeart Campaign

April 6, 2026 8:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today announced the expansion of its coordinated podcast marketing campaign to drive user adoption and engagement for its AI-powered mobile application, Snapshot Recipes. The expanded campaign extends beyond previously announced agreements with "Sibling Revelry" with Kate Hudson, "Wellness Unmasked" with Dr. Nicole Saphier, and "Native Land Pod" with Angela Rye, and now includes a...

Read more
American College of Osteopathic Family Physicians Convenes Experts for Disease Prevention Summit
Healthcare & PharmaceuticalConferences

American College of Osteopathic Family Physicians Convenes Experts for Disease Prevention Summit

April 6, 2026 7:00 AM

On April 15, ACOFP, in collaboration with sponsors Sanofi and Merck, will gather 25 osteopathic family physicians in Orlando, Florida, for a focused Disease Prevention Summit. This three-hour thought leadership session will bring together clinicians from across the country to address emerging challenges in vaccine confidence, access, and disease prevention in primary care. The summit is being held in conjunction with ACOFP's 63rd Annual...

Read more
Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector's Opportunity
Healthcare & PharmaceuticalCompany Update

Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector's Opportunity

April 6, 2026 6:00 AM

As cannabis stocks rally following new federal flexibility on hemp derived CBD products, investors are asking a deeper question: which companies are actually positioned to succeed under the emerging FDA led cannabinoid regulatory framework? Cannabis equities surged this week after the U.S. Food and Drug Administration announced it would exercise enforcement discretion toward certain physician-directed hemp-derived oral CBD products participating...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?